These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 8859190

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Urakami S, Shirakawa H, Ishibe T.
    Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.
    Shiina H, Igawa M, Urakami S, Shirakawa H, Ishibe T, Kawanishi M.
    Eur Urol; 1997 Dec; 31(1):73-80. PubMed ID: 9032539
    [Abstract] [Full Text] [Related]

  • 9. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A, Hadjiyannakis M, Dimopoulos D, Kamina S, Krikoni O, Alexopoulou V, Rigas C, Agnantis NJ.
    Eur Urol; 1997 Dec; 31(4):464-71. PubMed ID: 9187909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS, Feil G, Bichler KH.
    Anticancer Res; 2000 Dec; 20(6D):5023-8. PubMed ID: 11326661
    [Abstract] [Full Text] [Related]

  • 12. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
    Inagaki T, Ebisuno S, Uekado Y, Hirano A, Hiroi A, Shinka T, Ohkawa T.
    Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP.
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D, Ioakim-Liossi A, Karakitsos P, Aroni K, Kakoliris S, Kanavaros P, Kyrkou KA.
    Anticancer Res; 1997 Apr; 17(1B):781-6. PubMed ID: 9066620
    [Abstract] [Full Text] [Related]

  • 17. Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?
    Doganay L, Altaner S, Bilgi S, Kaya E, Ekuklu G, Kutlu K.
    Int Urol Nephrol; 2003 Apr; 35(2):181-8. PubMed ID: 15072490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, Georgountzos C, Thomas-Tsagli E.
    Pathol Res Pract; 1997 Apr; 193(11-12):767-75. PubMed ID: 9521509
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of nuclear p53 and tumor progression in bladder cancer.
    Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ.
    N Engl J Med; 1994 Nov 10; 331(19):1259-64. PubMed ID: 7935683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.